ECRG4 and Alzheimer disease: The expression of C2ORF40 alters in some brain cells of AD patients, which is probably implicated in the neuroimmune response in AD via recruiting the microglia or infiltrating monocytes to the white matter [49], while in status epilepticus, the infiltrating monocytes could enhance the inflammation of brain and accelerate neural injury [50].